Highlights:
- Peptone has installed an NVIDIA DGX A100 system at Verne Global’s HPC optimized data center campus.
- Peptone is the world’s first AI-driven Protein Engineering Operating System (PeOS).
- After three years of hard work by physicist and founder Dr. Kamil Tamiola and team developed a foundation of PeOS.
- PeOS by Peptone will manage massively parallel molecular simulations.
- NVIDIA DGX A100 supercomputer at Verne Global’s campus is powered by 100% renewable energy.
- Expert’s view on collaboration.
About installation of an NVIDIA DGX A100 system
Four months after introducing its seed round from Hoxton Ventures and dRX Capital, Novartis Pharma AG’s venture arm, Peptone, has installed an NVIDIA DGX A100 system at Verne Global’s HPC optimized data center campus in Keflavik, Iceland.
Peptone is the world’s first AI (artificial intelligence) driven Protein Engineering Operating System (PeOS). The company also declared a partnership with NVIDIA to advance its AI-driven protein engineering system to meet rising demands from the protein therapeutics industry.
After three years of hard work, the physicist and founder Dr. Kamil Tamiola and his team (physicists, computer engineers, structural biologists, and mathematicians) developed a foundation of PeOS.
In collaboration with NVIDIA, PeOS by Peptone will manage massively parallel molecular simulations, which are orchestrated and supervised by reinforcement learning algorithms.
The platform is developed to automatically find non-obvious protein variants with desirable therapeutic properties and cost-efficient manufacturability.
Peptone was chosen to colocate its new NVIDIA DGX A100 supercomputer at Verne Global’s campus as it is powered by 100% renewable energy and as part of the NVIDIA DGX-Ready Data Center Program, is optimized to support and maintain high density and HPC applications operating on NVIDIA infrastructures.
Expert’s views
Dr. Kamil Tamiola, Founder, Chief Executive Officer at Peptone, commented: “The business of protein therapeutics is a huge industry and as we grow and further develop our supercomputing capacity, we can help make significant progress in bringing sought-after protein-based treatments to market faster. Our collaboration with NVIDIA ensures that we have access to best-in-class AI and supercomputing hardware and support. The decision to locate our computing hardware in Verne’s Global facility in Keflavik transpires from our commitment to sustainability and security, as no other Tier-3 facility in this part of the world offers this level of operational resilience and runs on completely renewable energy sources. We are proud to be one of the first startups with our own supercomputing hardware operating on completely renewable energy sources.”
Craig Rhodes, EMEA Industry Lead for Artificial Intelligence Healthcare and Life Science at NVIDIA, commented: “GPUs are accelerating every phase of drug discovery, and in the early phases of drug development, they can massively reduce the time to market.”
He further added, “As an NVIDIA Inception member, our acceleration platform for AI startups, Peptone is showing remarkable success in the use of their technology to advance this area of discovery.”
Dominic Ward, Chief Executive Officer at Verne Global, commented: “We’re delighted Peptone has selected Verne Global as its data center partner at this mission-critical moment for the company.”
He further added, “Our facility, powered by 100 percent renewable geothermal and hydroelectric energy sources, is optimized for the secure and scalable high intensity computing required by Peptone to successfully meet the growing demands of the protein therapeutics market and accelerate the time to market of protein-based drugs.”
